Protagonist Therapeutics, Inc.
PTGXBiotechnology
$144.34+1.55%As of Oct 29vs prior close
- Market cap
- $9.3B
- P/E (TTM)
- 138.4×
- From 52W high
- −9.00%
- EPS (LTM)
- $0.79
- Revenue (FY25)
- $46M
- Dividend yield
- 0.00%
Nomior Score
76
Steady ProfileSpeculativeTop 4% of the scored universe
Growth50
Quality64
Value61
Momentum95
Resilience58
Growth
+10.93%revenue a year over 8 fiscal years
FY17 $20.1MFY25 $46M
Connections
Revenue to profitQ2 FY26
76% of revenue became net profit, up 703 pts on a year.
Who owns it
2funds, 2 tracked portfolios